202 results on '"del Papa, Nicoletta"'
Search Results
2. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
3. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?
4. Surgical treatment of recalcitrant gastroesophageal reflux disease in patients with systemic sclerosis: a systematic review
5. Autologous stem cell transplantation in scleroderma
6. Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)
7. Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients
8. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
9. Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity
10. Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
11. High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
12. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study
13. NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity
14. Classification and diagnostic criteria in Sjögren’s syndrome: a long-standing and still open controversy
15. Adipose-derived cell transplantation in systemic sclerosis: state of the art and future perspectives
16. Breakthrough Infections in COVID-19 Vaccinated Patients with Systemic Sclerosis: A Survival Analysis from a Multicenter International Patient-Reported Survey
17. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study.
18. New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies.
19. Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.
20. A Die-Hard Giant Capillary
21. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study
22. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial
23. The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features
24. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation
25. A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies.
26. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 infection
27. The story of the murine antiendothelial monoclonal antibody BGM: From patients' bedside to laboratory bench and from animal models to patients
28. BAG3 induces α‐SMA expression in human fibroblasts and its over‐expression correlates with poorer survival in fibrotic cancer patients.
29. Sjögrenʼs syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögrenʼs syndrome, derived from an analysis of a cohort of Italian patients
30. Bone Marrow Endothelial Progenitors are Defective in Systemic Sclerosis
31. Precocious Intima-Media Thickening in Patients With Primary Sjögrenʼs Syndrome
32. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease
33. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT.
34. Circulating Endothelial Cells as a Marker of Ongoing Vascular Disease in Systemic Sclerosis
35. Autoantibodies to Fibroblasts Induce a Proadhesive and Proinflammatory Fibroblast Phenotype in Patients With Systemic Sclerosis
36. Introduction: Autoimmune vasculitis: A good clinical and basic exercise
37. Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al
38. Thrombotic events in patients with systemic sclerosis treated with iloprost
39. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis
40. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies
41. Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations.
42. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts
43. Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series.
44. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
45. Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)
46. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
47. Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.
48. Management of primary Sjögren’s syndrome: recent developments and new classification criteria.
49. Sjogren's Syndrome Disease Damage Index (SjSDDI) and Disease Activity Measurement (SjSDAM): two scoring systems for the assessment of DD and DA in SjS, derived by the analysis of a cohort of Italian patients
50. The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.